StudyLabel,DateTimeCreated,StudyIdStr,AnnotatorIdStr,7b03292b-4886-4d92-aeaa-2a37b54c33f1_Is this article relevant for our review? (Full-Text Screening),7b03292b-4886-4d92-aeaa-2a37b54c33f1_Is this article relevant for our review? (Full-Text Screening)_Id,7b03292b-4886-4d92-aeaa-2a37b54c33f1_Is this article relevant for our review? (Full-Text Screening)_Notes,ac2d9483-8915-407f-be16-381e5e592082_What is the reason for exclusion?,ac2d9483-8915-407f-be16-381e5e592082_What is the reason for exclusion?_Id,ac2d9483-8915-407f-be16-381e5e592082_What is the reason for exclusion?_Notes
Root,2022-03-21 18:41:34,01c35aeb-f00a-4369-b0bc-9ab61d7f6452,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,b1068c02-3aaf-405c-b3a2-08c8641bab44,,,,
Root,2022-03-22 11:16:24,01c35aeb-f00a-4369-b0bc-9ab61d7f6452,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,01c6975f-dc69-473b-9bba-18c887d24ad9,,,,
Root,2022-03-18 10:05:24,057046ea-e218-45cb-a35a-3decc91b15ec,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,c16632e3-743f-4aca-9ae6-03ea9ce9f424,,,,
Root,2022-03-24 10:08:16,057046ea-e218-45cb-a35a-3decc91b15ec,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,72ec3f33-7181-41f8-8ff3-6621764d968f,,,,
Root,2022-03-18 10:37:32,061c86fa-f333-4c2e-81d3-0aa9fc784d64,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,068a6c99-fb4e-41e8-ac2b-e78e50c4ec0f,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,94b179ed-08fe-43ea-bc5c-0eeede955590,
Root,2022-03-24 13:11:32,061c86fa-f333-4c2e-81d3-0aa9fc784d64,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,468e7f4a-7743-421c-b2e5-e105d48f98a9,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,0e7c3134-44d5-4882-a163-23a98e65a08d,
Root,2022-03-17 13:58:36,06fa8e0d-37c6-408f-b1cc-ea313c1a6bcf,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,91f318ce-1b63-4e0b-a033-b0e6a1529274,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,b763e817-901a-4c70-b274-612ba9e3710b,
Root,2022-03-25 10:46:17,06fa8e0d-37c6-408f-b1cc-ea313c1a6bcf,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,,,,a83fc0bb-d1c2-4be6-a47d-722444afcd76,
Root,2022-03-25 10:46:17,06fa8e0d-37c6-408f-b1cc-ea313c1a6bcf,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,,,,a83fc0bb-d1c2-4be6-a47d-722444afcd76,
Root,2022-03-25 10:46:17,06fa8e0d-37c6-408f-b1cc-ea313c1a6bcf,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,a1b9f46c-b711-4a7e-9835-df9d8c3db9ab,,,,
Root,2022-03-25 10:46:17,06fa8e0d-37c6-408f-b1cc-ea313c1a6bcf,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,a1b9f46c-b711-4a7e-9835-df9d8c3db9ab,,,,
Root,2022-03-24 18:27:00,08014b49-d8a2-4564-b17a-54f0227dc24f,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,6d5749a3-acc0-4cdc-b5da-adb362391e4c,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,dc5bea7a-0933-49b7-b83b-dde2541e438b,
Root,2022-03-26 18:39:08,08014b49-d8a2-4564-b17a-54f0227dc24f,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,38f3024e-84a0-4b53-a08a-bb11bde7d9d6,,no DMEM used / medium not clearly reported,8547ad54-4a09-46f7-9e4c-b91fbba8acb1,medium unclear
Root,2022-03-24 16:56:48,0b2b2f04-bc53-467a-8066-74b993761b51,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,0d281a28-f95f-4cfd-9284-9d6347f7633f,,no DMEM used / medium not clearly reported,f558a40e-e8b5-4ec4-8c76-7dc01069c57f,
Root,2022-03-26 16:37:48,0b2b2f04-bc53-467a-8066-74b993761b51,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,bb5651d8-350d-4f5a-9c7f-df375fc8fecc,,no DMEM used / medium not clearly reported,5cd080a5-c972-46b8-b44b-93d3a5592985,EMEM
Root,2022-03-21 16:36:09,0bf01b7d-12c9-494f-bbea-3d81211bbf8f,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,ee7c0c75-0996-4899-89ed-fea862fa74c9,,no cell viability/proliferation assessment,46722ac9-84c2-4ff0-9f8a-58cffe726eab,
Root,2022-03-22 13:28:24,0bf01b7d-12c9-494f-bbea-3d81211bbf8f,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,36324795-5b57-4ff8-b265-2ca429ac00ad,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,cb48953a-6d88-4941-a956-167b727af4a4,
Root,2022-03-22 11:03:15,142eb304-e80f-4a72-859d-7694628c11ff,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,eae3bd23-a407-43d0-977e-a18599f81238,,no cell viability/proliferation assessment,368668b9-4390-42b8-8a4c-517554d1a35b,only clonogenic assay -> exclusion
Root,2022-03-24 12:32:05,142eb304-e80f-4a72-859d-7694628c11ff,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,8334121a-2aa9-4776-9a7b-12c8db341194,,,,
Root,2022-03-18 10:08:04,1912be7a-f26d-435f-b938-f5e571a532ef,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,e2ee166b-443b-4923-80f5-3e78da9bc692,,no DMEM used / medium not clearly reported,5ab77d3f-e030-4200-8034-6863cb91eb3a,RPMI1640 medium
Root,2022-03-24 17:16:34,1912be7a-f26d-435f-b938-f5e571a532ef,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,88e101f2-efbc-4c01-a9c2-5764da5320a0,,no DMEM used / medium not clearly reported,4ab8e006-f6c1-48d5-9574-36ace7125b15,
Root,2022-03-18 10:34:13,1932ead6-8f56-43b1-8d16-2c1270ec1f2e,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,438303cb-d458-4dde-a0fe-97769aff80ca,,,,
Root,2022-03-25 10:51:06,1932ead6-8f56-43b1-8d16-2c1270ec1f2e,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,98da3a7c-589c-48a0-8b3b-5b2c2bef15da,,,,
Root,2022-03-21 19:21:15,1a5ffe14-2588-42eb-81f6-b1a4eb9eaab7,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,79a8e446-c036-4e7f-813c-c820322a15cf,,,,
Root,2022-03-24 15:50:37,1a5ffe14-2588-42eb-81f6-b1a4eb9eaab7,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,413e4f33-398a-4f15-b3ab-0d212f8cd4ee,,,,
Root,2022-03-17 10:44:02,1e72f320-a051-45fa-bbda-030afd12a7d3,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,882f425a-0ed5-4d43-8189-627017b22b6f,,no DMEM used / medium not clearly reported,51c3d300-b968-49ad-bb9d-9034d04966f2,RPMI 1640
Root,2022-03-25 08:52:49,1e72f320-a051-45fa-bbda-030afd12a7d3,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,3a7f93df-d751-45de-8b2a-2a2defc23aaf,,no DMEM used / medium not clearly reported,32bb3984-f278-464a-be90-806406ed9136,
Root,2022-03-19 10:07:35,1e899bf3-1563-4f52-9f26-ea3be131301d,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,1a960d02-b6da-4687-83f0-2f46b0c5a059,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,9a7ef79d-9c76-4e7f-8a66-f9cf65cdc44d,and EMEM medium
Root,2022-03-24 17:42:23,1e899bf3-1563-4f52-9f26-ea3be131301d,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,aeea846d-ff32-4f4e-88b3-d9417761ebd9,,no DMEM used / medium not clearly reported,c479b938-718f-420b-a599-98da8a5a3f78,
Root,2022-03-17 23:45:16,21210901-0644-4180-bc51-b3c203a7f30b,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,d1f8fd7a-b534-4d90-b813-fa6acf5d42ce,,,,
Root,2022-03-24 09:45:47,21210901-0644-4180-bc51-b3c203a7f30b,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,f1baa3b9-5e31-47a0-a57c-b0e7dc21309f,,,,
Root,2022-03-24 09:11:55,23b4e656-ae2c-45b1-a8c7-39a98f5641a9,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,4af5268f-361e-427b-96d5-ed334496349d,,,,
Root,2022-03-26 16:48:03,23b4e656-ae2c-45b1-a8c7-39a98f5641a9,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,035d0148-1fbd-4538-b007-f6ed8fb2402d,,,,
Root,2022-03-25 10:53:53,240725b1-7ae0-4cf5-9db5-243d3977aad6,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,7453f5f1-a29b-42a5-8c5d-88a5d0f7258a,,no DMEM used / medium not clearly reported,8a7e7e52-7647-494d-a8c7-a7d060ae745d,
Root,2022-03-25 18:50:47,240725b1-7ae0-4cf5-9db5-243d3977aad6,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,0f613454-d32a-4914-8e56-53bcec2c21d8,,no DMEM used / medium not clearly reported,2529031e-4cab-4faa-92b0-6f6631b314ed,EMEM
Root,2022-03-24 10:49:44,2489b321-ce0b-4443-a904-3e5c682398d6,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,df97b31d-cdee-487e-b6e5-7c36c587d350,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,6f94d532-8fa8-43d7-9381-343449f6aa89,
Root,2022-03-25 11:25:11,2489b321-ce0b-4443-a904-3e5c682398d6,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,a2a2e6ae-4d72-49c2-91b0-c0c2720e285c,,no U87 cells,5093add2-db34-4c3b-9bc6-55ccfb36e8ae,transfected U87 cells
Root,2022-03-22 13:23:50,267c65a2-1bb5-4da9-b91f-7ce13ecab392,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,ba3cd852-0482-4cdb-966c-843b97994870,,no U87 cells,a36c5ac7-a0ab-4fcd-8f62-7fb0c56b5c0c,only transfected U87 cells
Root,2022-03-25 11:12:56,267c65a2-1bb5-4da9-b91f-7ce13ecab392,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,3b6c2e52-fb02-446a-9606-58f2d5b882ee,,,,
Root,2022-03-24 18:14:46,27e5ff56-3108-40ce-b525-7f460a01bc29,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,24cf4b4f-9802-4d87-9406-7e9adf7d25d2,,no DMEM used / medium not clearly reported,e95b232f-b760-409e-8146-011272a96ed4,
Root,2022-03-25 18:56:48,27e5ff56-3108-40ce-b525-7f460a01bc29,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,ff5de3d5-893c-4be4-849a-f4ecc38dd360,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,d2531b37-42e8-4f09-b0ce-f57ab38b4a56,AND RPMI 1640 medium
Root,2022-03-24 10:15:27,29be3aa3-85d2-45f6-8cc5-33524c4806b2,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,b79b8d6a-7770-4abc-874a-a15234ba34ec,,,,
Root,2022-03-24 18:49:22,29be3aa3-85d2-45f6-8cc5-33524c4806b2,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,c4999276-2208-439b-b092-b07698434626,,,,
Root,2022-03-17 23:55:40,2a7ffb19-156c-4886-9824-782bb6ec9083,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,96e33091-68ba-4b88-b45b-f9afceea4077,,,,
Root,2022-03-24 10:39:06,2a7ffb19-156c-4886-9824-782bb6ec9083,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,2e399af8-1d0b-4cc4-bd74-35203d1348a4,,,,
Root,2022-03-24 15:56:25,2d316b74-704f-4e6c-8615-e73445337bde,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,48a273ac-22d9-459a-9ff9-06bd84434845,,,,
Root,2022-03-25 11:11:32,2d316b74-704f-4e6c-8615-e73445337bde,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,101693b1-6294-4028-ab0c-5f004379251f,,no cell viability/proliferation assessment,b7eb4706-80d4-4090-903b-0185f50afbf1,only IC50
Root,2022-03-22 13:26:52,2ed9e5f8-4bbf-4df9-bfba-3aea1369b628,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,f53c4551-f3d3-432a-a11f-5e67a6cf321e,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,8bab3566-7d8b-44f0-9d8e-97223e0e2311,
Root,2022-03-24 09:39:13,2ed9e5f8-4bbf-4df9-bfba-3aea1369b628,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,02c80fea-8998-4b1f-8947-8fb72e383a6d,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,9715a06e-f0b6-4564-b621-2d9efb410a88,
Root,2022-03-24 15:39:36,30eec7ef-8b46-4278-8035-b6d0cb9df5ea,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,67a4f7d8-ec8c-4ac7-93ef-285e5d3848a0,,no U87 cells,83d0399f-e6a4-42fa-aec2-a8b4645db50a,
Root,2022-03-25 11:26:44,30eec7ef-8b46-4278-8035-b6d0cb9df5ea,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,9b4a5264-280b-4813-8c97-134803bec582,,no U87 cells,e4a44b18-c3cb-4540-9813-3514d83e02f9,
Root,2022-03-19 09:50:38,3535f368-edc4-4291-989d-dc44fa6216e2,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,d03b8ce8-ac65-432f-a18e-85a2e7e39f13,,no DMEM used / medium not clearly reported,0e26f2fb-b452-41a1-8140-3ff0dbdcb502,EMEM
Root,2022-03-21 17:29:30,3535f368-edc4-4291-989d-dc44fa6216e2,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,ab6839b3-fd98-428d-945b-9c21b398f2c8,,no DMEM used / medium not clearly reported,149c197e-e818-4372-86a6-e131b1611589,
Root,2022-03-18 16:40:08,3deafa34-2e94-4886-ad77-3d4dcd184ebf,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,b052cc8d-4c2f-4a17-9e88-603e62ea6094,,,,
Root,2022-03-24 17:11:29,3deafa34-2e94-4886-ad77-3d4dcd184ebf,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,8152d029-9cbd-4c8b-a4f4-5a0658061962,,,,
Root,2022-03-22 10:37:19,4112c10b-19a6-4b6f-8681-f3700630bd77,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,835d5953-60ff-4518-a45a-437d3407dd9f,,no U87 cells,3d7dd290-0a59-4bbf-ac89-df97b6ebfb1d,lentivirus transfected U87 cells
Root,2022-03-24 12:40:08,4112c10b-19a6-4b6f-8681-f3700630bd77,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,88f3fbe1-6dda-4041-914e-fee49c53a877,,,,
Root,2022-03-24 10:03:45,41bba313-4111-40b5-be6e-bfd9a85b1362,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,5cfc5181-b3ab-4c0e-a11e-8c84706c299c,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,e1e28021-35c4-48c5-95ef-1fd6f5655559,
Root,2022-03-24 18:34:28,41bba313-4111-40b5-be6e-bfd9a85b1362,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,e72db206-2f77-45a6-a396-a914b06524b9,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,ec05cf88-4124-4109-bf2a-06431886be09,
Root,2022-03-17 13:56:02,44debb78-93d5-4c64-9e2a-8d7205c2b740,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,e5cfb189-69c9-4b37-915d-05205caa0368,,,,
Root,2022-03-24 18:30:33,44debb78-93d5-4c64-9e2a-8d7205c2b740,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,b7c1e626-c836-4bcb-94ba-f8921f29897e,,,,
Root,2022-03-24 18:19:02,44ff4dc0-b4a0-4295-bba6-21440f9d9437,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,2dd1a22b-da5b-4510-8f84-953a62949ccb,,no DMEM used / medium not clearly reported,6ecd69d4-599d-405b-85eb-152790c77055,
Root,2022-03-27 11:48:51,44ff4dc0-b4a0-4295-bba6-21440f9d9437,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,3f93597f-8a47-456f-946f-145a29846810,,no DMEM used / medium not clearly reported,aa2eff19-4204-4a5b-9da6-edbd2c31ee2e,Minimal Essential Medium (MEM)
Root,2022-03-18 10:50:06,4a5de13a-a78e-4f61-ad28-59d4e30680c0,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,6bae3e41-6873-4a67-9b46-fb53e963b17e,,,,
Root,2022-03-24 17:58:56,4a5de13a-a78e-4f61-ad28-59d4e30680c0,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,95b81823-0398-49d6-9d6d-008027d3271d,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,a7aef7ce-0728-42be-b111-4d5e7b0aae5e,
Root,2022-03-21 18:45:08,51f39755-93ec-4d06-97ca-b2891c45f37e,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,3a47cb08-75aa-43fd-bbae-d0dad1568b8d,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,2f90bc71-a6e0-4afb-b64e-50fc2e347a56,
Root,2022-03-23 18:30:21,51f39755-93ec-4d06-97ca-b2891c45f37e,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,b0edc78e-813c-426c-86d1-2634df7dbf38,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,31452d36-55f0-4a1c-b49f-a2875d8259cb,
Root,2022-03-19 14:20:42,53783bb3-0567-489f-932e-ce5e30ac3899,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,f3c443dd-86dd-438f-ad1d-045258691d8e,,no DMEM used / medium not clearly reported,a902f317-30d5-4869-92bf-82d873834651,MEM
Root,2022-03-24 10:28:47,53783bb3-0567-489f-932e-ce5e30ac3899,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,2ab49ae6-2842-4174-b51f-32890eedc451,,no DMEM used / medium not clearly reported,4aac30f5-0d5b-48bb-b659-5590cebb4373,
Root,2022-03-24 16:59:39,54f14ed5-8dec-47e7-ba05-731064209336,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,3e69c737-958d-4a9b-87e3-bd8e20a3dbf6,,,,
Root,2022-03-25 14:34:14,54f14ed5-8dec-47e7-ba05-731064209336,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,d3501d0c-8d06-439b-a46d-9b4e8334459c,,,,
Root,2022-03-17 10:42:42,58bccc12-fc0e-4693-b9f7-700a6af2b22d,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,,,,2db42154-8b03-4413-93e8-f9c4b419df65,unclear medium
Root,2022-03-17 10:42:42,58bccc12-fc0e-4693-b9f7-700a6af2b22d,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,,,,2db42154-8b03-4413-93e8-f9c4b419df65,
Root,2022-03-17 10:42:42,58bccc12-fc0e-4693-b9f7-700a6af2b22d,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,8f24f167-6a96-4e8c-80a0-8340bf1aa675,,,,unclear medium
Root,2022-03-17 10:42:42,58bccc12-fc0e-4693-b9f7-700a6af2b22d,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,8f24f167-6a96-4e8c-80a0-8340bf1aa675,,,,
Root,2022-03-24 18:43:27,58bccc12-fc0e-4693-b9f7-700a6af2b22d,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,7587a35a-b526-48f1-817d-8c0027e865ad,,no DMEM used / medium not clearly reported,d0f65cfd-d056-44fa-b734-c20debdace8c,
Root,2022-03-18 16:42:46,59810855-3a60-4f65-b4cf-68902c375084,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,6a9ef777-4a81-47a2-bbb9-843ab876acb8,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,f2b26969-9ffe-4993-991e-a8f13c502e14,
Root,2022-03-24 10:24:54,59810855-3a60-4f65-b4cf-68902c375084,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,60d389d0-cfeb-4a8d-b078-61e4eecc090f,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,7254c5b1-f924-4b0c-b8da-547b4d5396e4,
Root,2022-03-24 18:41:29,5cc8c869-344c-49f8-ba1e-5af7fa302727,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,32f57e82-2c0c-4fa1-a4c0-05c9ffe1d688,,,,
Root,2022-03-27 11:48:10,5cc8c869-344c-49f8-ba1e-5af7fa302727,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,9efdda95-360a-4998-a411-ee52b6dcfd7b,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,ff618fdd-0f4e-4313-8a32-dca3a7ca71d1,transfected U87 cells
Root,2022-03-25 11:07:08,5f1cea34-0312-40b6-bb26-023a3de4e9c6,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,d2ce9ed1-3b23-487b-94ca-73672e25169c,,no DMEM used / medium not clearly reported,601bb974-2137-4889-b7fa-5388d327d036,
Root,2022-03-25 13:08:23,5f1cea34-0312-40b6-bb26-023a3de4e9c6,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,a4074362-8f14-4540-9527-6a87b0206d1d,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,bee2a379-0630-4616-97e1-77d93f55cdbf,AND RPMI-1640 medium (Gibco)
Root,2022-03-21 16:05:28,66215c71-6746-4c75-95d2-d44040393def,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,56ee7ba4-423d-47a9-807e-3377eaf38ab6,,,,
Root,2022-03-22 11:19:27,66215c71-6746-4c75-95d2-d44040393def,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,92566a70-a614-4cfe-8d1d-1f0fae299df0,,no U87 cells,fe591a64-b1e3-4c3d-b7d6-fd42472f4218,divided into non-GSC and GSC U87 cells
Root,2022-03-23 18:41:58,69c62bf2-3be0-48af-991d-3cea8d9507a4,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,8ca23410-438a-4831-8334-59d74dee139a,,no cell viability/proliferation assessment,d06fecd5-aeff-4086-9f66-072f296d08dd,only IC50
Root,2022-03-25 08:44:03,69c62bf2-3be0-48af-991d-3cea8d9507a4,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,996accb4-2e13-45a2-b0da-538391847d53,,,,
Root,2022-03-24 10:39:47,6a17c9de-9be4-48b7-a6a4-e2d23b3f3eb9,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,060c7bc2-407d-440e-928e-8f44f4ef20d0,,no DMEM used / medium not clearly reported,87042aff-7b19-4de5-9bda-2c57b3637cec,
Root,2022-03-25 11:13:58,6a17c9de-9be4-48b7-a6a4-e2d23b3f3eb9,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,0cb6a0ae-b98d-4c31-984b-3c508ca16a19,,no DMEM used / medium not clearly reported,4987116d-2c67-4869-8101-ac2462809cfe,Eagle’s minimum essential medium (EMEM)
Root,2022-03-22 11:36:09,6aad6b36-03be-483e-997a-195f37e12ba6,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,608f19de-3e91-46fb-9f93-410051ca3466,,,,
Root,2022-03-25 09:29:30,6aad6b36-03be-483e-997a-195f37e12ba6,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,4b2cee25-4ccb-4177-9c24-01d2312bbc64,,,,
Root,2022-03-21 16:39:13,6cc0b6c9-702b-4a8c-9e50-403b92444766,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,7678db77-9a5c-4b4f-84e3-625e127d5503,,no original peer-reviewed research article,969d0f60-7efd-47d9-83ad-f327a31634e3,
Root,2022-03-22 10:50:12,6cc0b6c9-702b-4a8c-9e50-403b92444766,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,0b695895-4e53-4b6f-8e36-c49eb71ff85f,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,35236c1d-e24b-4484-bd02-75413d10910d,review without own experiments
Root,2022-03-19 14:17:56,6e252884-a3d1-4b98-82fd-e75b58b8bfd7,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,5cd277b9-9efc-42b4-82a3-b9029a726651,,,,
Root,2022-03-24 18:17:45,6e252884-a3d1-4b98-82fd-e75b58b8bfd7,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,84f49026-b354-44b9-9a21-893ca71d741f,,,,
Root,2022-03-18 10:35:42,6e93329a-3c0a-4e17-bbac-c99458fc59c7,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,c484e658-5caa-4852-b06c-3f8681f04a99,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,32d59441-1cab-4e0b-97c3-716797111497,
Root,2022-03-24 17:57:35,6e93329a-3c0a-4e17-bbac-c99458fc59c7,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,d29662f7-e6be-4943-9843-8d5582fed1d0,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,19613b34-2da8-49e2-b706-463d414912fc,
Root,2022-03-24 12:25:59,700d87ca-2cd4-4f21-a5d8-2096588e8a0e,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,2c75a640-2c9b-4adc-8ea4-cbf98f4f8659,,,,
Root,2022-03-26 16:35:39,700d87ca-2cd4-4f21-a5d8-2096588e8a0e,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,,,,3afb7a77-6c59-4358-aef3-4801857dea50,"U87MG human GBM cell line overexpressing EGF receptor variant III (EGFvIII) (EGFR+ cells) (kindly provided by Prof. Pier-Luigi Lollini, University of Bologna, Italy) or overexpressing empty vector (EGFR-)"
Root,2022-03-26 16:35:39,700d87ca-2cd4-4f21-a5d8-2096588e8a0e,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,,,,3afb7a77-6c59-4358-aef3-4801857dea50,
Root,2022-03-26 16:35:39,700d87ca-2cd4-4f21-a5d8-2096588e8a0e,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,609858e3-53e6-419c-b5bb-4c6915ee418a,,,,"U87MG human GBM cell line overexpressing EGF receptor variant III (EGFvIII) (EGFR+ cells) (kindly provided by Prof. Pier-Luigi Lollini, University of Bologna, Italy) or overexpressing empty vector (EGFR-)"
Root,2022-03-26 16:35:39,700d87ca-2cd4-4f21-a5d8-2096588e8a0e,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,609858e3-53e6-419c-b5bb-4c6915ee418a,,,,
Root,2022-03-22 10:48:57,727af27b-7e97-4231-8990-d5c66c2716bd,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,f3418e80-44a7-49b3-beae-9d34690ec578,,,,
Root,2022-03-25 09:11:32,727af27b-7e97-4231-8990-d5c66c2716bd,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,e549de9d-651f-438d-b8c0-631a914dc7bf,,,,
Root,2022-03-21 19:44:50,74149196-6f57-457c-9ad0-38d8e50504b6,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,f30847a1-fb80-4013-a70a-ec37d46e11e2,,,,
Root,2022-03-25 11:04:50,74149196-6f57-457c-9ad0-38d8e50504b6,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,ba58f76d-d7af-4591-b4da-2e7896bd8109,,,,
Root,2022-03-22 13:50:29,77b88bb7-4304-410a-bfa2-b0bed8a80e0a,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,935a6076-3492-47b4-993b-dfa8b5ff9553,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,0dd73062-1794-4207-b25e-23fb6f9badc6,
Root,2022-03-24 15:46:42,77b88bb7-4304-410a-bfa2-b0bed8a80e0a,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,732ab304-f32d-418f-8e91-aacf080a054e,,no DMEM used / medium not clearly reported,65b2d8d3-88d0-4874-a1b6-68b052821ae1,
Root,2022-03-23 17:50:38,8109c2d8-887f-443f-aa5f-2662efbde49b,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,5307476c-cd0f-4a41-be67-77fb2d14b44f,,,,
Root,2022-03-24 09:18:37,8109c2d8-887f-443f-aa5f-2662efbde49b,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,d88de8cb-94f8-4030-9c43-f3b7d8284732,,,,
Root,2022-03-21 16:37:59,84c70283-27af-4c6a-972b-f5843b945c94,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,2df813ff-fae3-44fb-8e41-757fe30eb2bc,,no DMEM used / medium not clearly reported,f0fb743f-207b-456b-b1aa-e2adde98c465,
Root,2022-03-25 11:32:21,84c70283-27af-4c6a-972b-f5843b945c94,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,2c00b374-b3c3-47cc-88c5-0469f6d2d446,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,18c579c6-4e79-4d49-8675-ad108c48b6bf,
Root,2022-03-24 15:32:18,85d22acb-4f69-4c31-9467-54ae3746388c,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,acfec5d0-0612-4f5f-9c30-572cf489817a,,,,
Root,2022-03-25 18:41:39,85d22acb-4f69-4c31-9467-54ae3746388c,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,673465ab-281d-44d9-865c-4552aab2d142,,,,
Root,2022-03-19 10:19:43,8816a729-b375-4765-bd1f-b0fb42f606c5,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,a5e2b0cd-4e80-4516-879d-73e825540824,,no DMEM used / medium not clearly reported,ffa6fce2-8c55-4013-b35e-e38d36ce1937,Minimum Essential Medium
Root,2022-03-24 18:07:17,8816a729-b375-4765-bd1f-b0fb42f606c5,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,9c668a2d-9899-4dd5-be28-d760ae544623,,no DMEM used / medium not clearly reported,b2cdac09-b23e-4028-a913-f814d50126ed,
Root,2022-03-24 18:37:10,8bbf5c55-79b8-442f-ac26-9017b03552d8,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,f8598ecf-fb3b-4957-a26a-2f2cd26488fb,,,,
Root,2022-03-26 17:00:25,8bbf5c55-79b8-442f-ac26-9017b03552d8,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,d3a67007-a2b8-46e7-b73f-e3ae9406ed91,,,,
Root,2022-03-19 09:52:53,919e413b-1bdc-4439-bc36-b0b5f256fced,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,e0dcbfcb-9b3a-4d11-9cb7-eb6126d7f1be,,no DMEM used / medium not clearly reported,20ec7eb6-dbe5-4b49-8a73-3dd78ce3ede0,EMEM
Root,2022-03-24 10:50:41,919e413b-1bdc-4439-bc36-b0b5f256fced,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,f01e1c8d-7db3-41c0-b73f-4f4dabceebab,,no DMEM used / medium not clearly reported,088a6040-0b06-466e-bc53-91d62f0d8b29,
Root,2022-03-23 18:13:44,952b23ea-938a-42ca-9db8-d21cc2c93d31,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,e6d8fad7-8f3b-415b-88fb-d9e9d7bb2dcd,,no DMEM used / medium not clearly reported,8869cfb2-c2f5-4a2e-bc89-34f2f0715e6b, RPMI-1640 medium
Root,2022-03-24 13:28:20,952b23ea-938a-42ca-9db8-d21cc2c93d31,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,1c130a3d-d6ec-4589-b9a9-5c55baa7d264,,no DMEM used / medium not clearly reported,95894ce0-56f0-4b1d-a89f-6054de25225f,
Root,2022-03-19 10:16:30,958b7555-a76b-4473-aa12-50201a48860b,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,bac90631-9526-4e7e-8afb-9e1c49193229,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,f4b8a777-8fa2-45fb-ab95-13940a025cc2,
Root,2022-03-24 16:33:51,958b7555-a76b-4473-aa12-50201a48860b,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,91492c3c-5a86-433d-88fb-cf519eb1a665,,no DMEM used / medium not clearly reported,c94c4647-9a47-4b47-9f6c-c06b911c0463,
Root,2022-03-24 17:07:19,972aa89d-1765-4999-b686-68107b6b36ee,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,c8fb9d5d-7de8-4749-8f03-8fdcf13f8ce2,,,,
Root,2022-03-27 11:40:23,972aa89d-1765-4999-b686-68107b6b36ee,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,3db0f552-8553-4240-8a8c-b21a512bf2d4,,,,
Root,2022-03-19 10:28:53,98427cd0-1ead-4dbe-98fc-50f7be3f76c3,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,2a50db13-00f4-4770-9419-ffaca80888fd,,,,
Root,2022-03-25 08:49:41,98427cd0-1ead-4dbe-98fc-50f7be3f76c3,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,615549b9-b0b3-4936-8f1b-f450e282f8fc,,,,
Root,2022-03-21 17:19:24,a0f71eea-ea45-4513-a7ed-38d6590a1e7a,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,4f46c737-9e0a-477b-a69a-f4e412359622,,no cell viability/proliferation assessment,f631116e-8d59-4442-a585-8c77a09edf32,
Root,2022-03-23 18:34:48,a0f71eea-ea45-4513-a7ed-38d6590a1e7a,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,477a2f26-4a34-42e6-9a62-e5ade43e7514,,no cell viability/proliferation assessment,b1173285-1cad-437b-9255-80ccacca3161,only colony formation assessment
Root,2022-03-24 09:35:32,a1acbb60-cabb-46ba-b849-0257df1533a5,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,2b7d70db-fc90-4c34-a121-da92fe0acc4b,,,,
Root,2022-03-25 11:55:11,a1acbb60-cabb-46ba-b849-0257df1533a5,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,d691acc1-aceb-46c7-8cab-e65b7f7a921d,,,,
Root,2022-03-24 15:43:16,a38a8e0e-adff-4be5-a3eb-81b96f9e37fe,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,9fc71ea9-18ef-4326-851f-5be88375a55d,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,4cbaad46-6ef8-4dd4-913d-6be2e39164fb,
Root,2022-03-25 11:29:18,a38a8e0e-adff-4be5-a3eb-81b96f9e37fe,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,49177a8c-d0a1-470a-af50-b54367051c22,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,743e5104-7d25-4849-8ef8-031e3204127f,
Root,2022-03-22 13:48:09,a9cced18-b11d-4dc7-90a5-4186440479e0,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,195b539b-7c8b-445a-8a53-877a603f5480,,,,
Root,2022-03-24 15:37:33,a9cced18-b11d-4dc7-90a5-4186440479e0,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,cd63f4b9-3f05-488a-8d1d-a01aa0c65d65,,,,
Root,2022-03-23 17:51:19,abd3784f-9c67-4d23-94d7-a414e576ee14,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,6b8b1cb4-2876-4548-9bed-cdd34d294afc,,no original peer-reviewed research article,2c589751-cd15-49f9-a420-71804183e69f,conference poster abstract
Root,2022-03-25 13:23:56,abd3784f-9c67-4d23-94d7-a414e576ee14,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,2d1a315f-0587-4ac1-aeda-26a734275e50,,no original peer-reviewed research article,6612564e-2192-42f3-8ed9-82b664ac4677,
Root,2022-03-22 10:18:56,aee9305e-f569-4968-9534-f5a2e4405363,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,0bda97cb-5ed8-4738-b094-cb7422b4f29f,,no cell viability/proliferation assessment,98490fa6-3064-47c6-a4f4-a0a86b5ebccf,only colony formation assay -> is not included in our review
Root,2022-03-25 11:20:11,aee9305e-f569-4968-9534-f5a2e4405363,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,9321820e-86aa-4c34-8a33-8e721e1848f6,,no cell viability/proliferation assessment,3f44cca0-07df-4a6b-b1e1-cde0668fdcd4,
Root,2022-03-18 11:00:40,afb51732-b5b4-4a0d-95ff-a22836cacc5b,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,f1c8fc3b-30f2-4d81-80eb-1859b82dc1c6,,,,
Root,2022-03-25 11:01:07,afb51732-b5b4-4a0d-95ff-a22836cacc5b,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,e1ca1809-6c2c-45a1-a2f6-256574fc02a8,,,,
Root,2022-03-24 15:40:45,bb246950-ca16-426e-9a50-980f782570c7,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,eff2e047-e947-4f1d-8013-6e2bce12416b,,no DMEM used / medium not clearly reported,818d988f-fe40-4789-bef6-bd39c3f4f0ec,
Root,2022-03-25 13:09:54,bb246950-ca16-426e-9a50-980f782570c7,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,a1337991-3de4-4e7b-83e2-2df7d9dd6d31,,no DMEM used / medium not clearly reported,04952730-8b07-4253-85d7-7a3e255c65f7,EMEM
Root,2022-03-24 09:51:48,bb86b452-9aa2-47d5-9673-3a30e8868704,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,a0258508-4da3-4b50-a9af-b12766a8b345,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,0545d638-c56d-4094-81f3-f192a7a85aca,
Root,2022-03-26 18:37:34,bb86b452-9aa2-47d5-9673-3a30e8868704,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,5ed24318-8666-44a0-bef3-5b3650339079,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,c2d91c60-adc1-4edc-a566-5a431be3e4d3,
Root,2022-03-24 17:41:12,bcc38976-1383-45a0-b0ce-ce5ffd96812b,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,43ab0e6e-1625-421c-914d-64f1d919680e,,,,
Root,2022-03-24 19:06:52,bcc38976-1383-45a0-b0ce-ce5ffd96812b,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,cf93932c-a06f-48df-9b36-c0fc9204619a,,,,
Root,2022-03-22 10:31:08,bcf7acb7-6422-445d-9690-270344b456fe,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,86935a91-eb88-4cc8-9a08-ed5dee5283ca,,,,
Root,2022-03-24 10:34:21,bcf7acb7-6422-445d-9690-270344b456fe,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,1117b355-c456-4f09-980b-478799c094c9,,,,
Root,2022-03-19 10:04:00,be089bd7-9b71-4425-a8ee-f019896999d9,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,c64dc9fa-22a7-449f-a474-aa10257f4529,,,,
Root,2022-03-24 13:10:06,be089bd7-9b71-4425-a8ee-f019896999d9,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,bf01cbb4-0700-434e-9bfb-70619638a533,,,,
Root,2022-03-25 11:09:26,be5315c5-1b74-4bbf-b411-f2a395ad7911,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,3d179d02-a4ce-4252-8bed-18c317430b86,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,1144944a-3ff7-400c-8883-25b2a2664222,
Root,2022-03-25 18:47:40,be5315c5-1b74-4bbf-b411-f2a395ad7911,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,df9cd309-6471-48a8-a8bf-249d511d1d8c,,no cell viability/proliferation assessment,82e63be1-f863-4561-bd15-36e15c779a96,only clonogenic survival
Root,2022-03-18 10:07:10,bf16c4b1-fc66-467d-830b-bbe7d4bef9c5,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,86ff7505-e22c-4b91-9cba-a8e130d9ce10,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,ccffbfd5-5e1b-422a-a67a-b1594679a704,
Root,2022-03-24 17:02:04,bf16c4b1-fc66-467d-830b-bbe7d4bef9c5,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,8452dc6d-e297-43cc-aa70-5ff19409ab39,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,d203c2c2-d00d-4d02-b562-610859358ab9,
Root,2022-03-23 18:38:23,c1a52334-d9af-456c-bd86-8c410220e8d9,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,076f58eb-5d59-4a08-91f7-f9c0d841c6d7,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,294703ba-5a1d-4b65-8048-c208ffd50372,
Root,2022-03-24 12:50:21,c1a52334-d9af-456c-bd86-8c410220e8d9,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,7d5abfea-e028-4e97-8031-c79f17ca33a7,,,,
Root,2022-03-21 16:58:09,c3293c33-9d69-4973-b22a-9abc45e06030,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,42586b0f-dc5a-4291-9031-b9d383d7a173,,no DMEM used / medium not clearly reported,c6d88050-5c89-4293-b466-fbaa916e28d5,
Root,2022-03-24 18:57:56,c3293c33-9d69-4973-b22a-9abc45e06030,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,bdc34bda-b40f-48da-9f16-c0bfca0a7701,,no cell viability/proliferation assessment,6b32103b-70f0-4c59-a142-4b4df80abc33,
Root,2022-03-19 00:20:58,c448ca29-4ed8-45f7-872d-2dde10f245d3,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,60361485-02d3-467c-b374-ba2fb5155e2d,,,,
Root,2022-03-25 09:02:14,c448ca29-4ed8-45f7-872d-2dde10f245d3,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,39c88aa2-9ac5-462b-b0a8-9ee6d018582b,,,,
Root,2022-03-23 18:36:53,c556ad39-ec8b-4d48-ba27-a9d02b69edf1,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,ec135ba2-3b99-4f09-88b5-7c3db75f2d91,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,86475a2a-5088-41b4-a381-6bbbcfb1fe10,
Root,2022-03-24 18:06:46,c556ad39-ec8b-4d48-ba27-a9d02b69edf1,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,feaaafc4-c21e-40c2-aead-e4511cbe39a5,,,,
Root,2022-03-23 18:23:59,c716aeff-6d94-46f6-ba16-04b109000936,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,77db0d44-6470-4133-8533-8154ffc7c3de,,,,
Root,2022-03-24 09:29:46,c716aeff-6d94-46f6-ba16-04b109000936,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,00213867-8bfe-49ad-a629-533ab26079c6,,,,
Root,2022-03-19 10:13:32,c9d3d38b-883c-4926-813a-45333b573f71,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,36ab319d-a24b-476b-941d-14343cfc79ce,,,,
Root,2022-03-24 16:32:36,c9d3d38b-883c-4926-813a-45333b573f71,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,75f77f9c-84bb-4ac9-ab69-ef7030e701af,,,,
Root,2022-03-24 17:56:17,cad814c6-59d0-4aee-964b-402b510b2b08,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,7565eff2-f938-44fc-ac74-c66e91d638b1,,,,
Root,2022-03-25 12:07:24,cad814c6-59d0-4aee-964b-402b510b2b08,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,fec2ee62-b775-4fd6-aa03-3ca00ea98bf6,,,,
Root,2022-03-23 18:25:11,cc49796d-6383-468c-bb05-66e9c6857487,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,126775d2-2db8-4224-ae71-93b143fdf504,,no DMEM used / medium not clearly reported,d5b76f9d-5b83-4da7-82ab-70771860204e,MEM and DMEM/f12
Root,2022-03-24 12:41:05,cc49796d-6383-468c-bb05-66e9c6857487,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,88d55edf-7cde-44fd-844e-4afec9b2b8e9,,no DMEM used / medium not clearly reported,8c88b334-131d-4940-92a5-612b892d24bf,
Root,2022-03-17 10:57:56,cca1ed1d-e9e8-44b7-accd-4231658363b1,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,fff652c0-d880-45b0-b3a4-261157fbb4cf,,,,
Root,2022-03-24 16:00:19,cca1ed1d-e9e8-44b7-accd-4231658363b1,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,0f7a101f-3f0f-403f-89ee-3680eb0b15e4,,,,
Root,2022-03-24 18:31:28,cf1e1c10-0da6-44be-b831-43f31350d97e,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,b80569c5-0574-45c1-8035-28bdaf4b8f1b,,no DMEM used / medium not clearly reported,870c8fad-28b2-4580-a4af-3044a415de34,
Root,2022-03-24 18:55:54,cf1e1c10-0da6-44be-b831-43f31350d97e,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,ac22cb0b-621b-41fe-9c3d-0e8a4ee20d51,,no DMEM used / medium not clearly reported,1e7b37eb-e22f-4fcd-826e-758e3e87f6a9,DMEM/F-12 medium
Root,2022-03-22 10:14:38,d046fea2-07c8-4970-b3c6-50118ef891f4,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,785aa112-8354-4ea1-8607-dcd61d8fbfb6,,,,
Root,2022-03-24 09:03:05,d046fea2-07c8-4970-b3c6-50118ef891f4,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,82c2223b-4c8b-4317-88cb-d7643e120d93,,,,
Root,2022-03-23 18:12:37,d5c7f846-d04a-42e0-af7c-b65f7bcb4cce,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,949e94f5-eb9e-49ee-acee-c3985bf22924,,,,
Root,2022-03-24 16:55:57,d5c7f846-d04a-42e0-af7c-b65f7bcb4cce,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,6aa3fb5a-dda2-404c-b85e-b20bd7cdda7c,,,,
Root,2022-03-24 17:15:40,d60c33b7-5641-4cd9-a5ff-0a72ac41f4ab,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,140b26ae-1081-459b-aa9e-dac553f86930,,,,
Root,2022-03-25 11:45:42,d60c33b7-5641-4cd9-a5ff-0a72ac41f4ab,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,667640c2-ae61-4c38-a583-c05d06c550dd,,,,
Root,2022-03-17 13:14:29,d643df11-d366-487d-a3cc-332631ff13f4,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,3203f79e-5691-4760-b736-d042859d2127,,,,
Root,2022-03-25 09:19:27,d643df11-d366-487d-a3cc-332631ff13f4,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,73b43d3a-b776-4b4a-be25-ba812cbed837,,,,
Root,2022-03-22 13:38:20,d8231c09-2b12-4917-8f00-3203f08f8c0b,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,a46d1407-312a-425b-9c99-476e76a8bbe6,,,,
Root,2022-03-25 09:16:14,d8231c09-2b12-4917-8f00-3203f08f8c0b,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,e83f4ae3-5a9d-419f-8900-77e1467d8458,,,,
Root,2022-03-24 09:21:02,dc34f637-69dd-481d-9919-c9bd1a02adf6,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,68d1cfac-741b-4b73-8558-a0bb5ee3fd64,,no DMEM used / medium not clearly reported,dc81c9b6-2549-4ae8-b8d5-8bea1c5d60c6,
Root,2022-03-24 18:53:52,dc34f637-69dd-481d-9919-c9bd1a02adf6,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,57cef4db-35f9-4d17-a03d-a39038849c87,,no U87 cells,3521e779-2170-4f57-ae5c-72d89a8f85de,U87 stem cells and DMEM/F12 medium
Root,2022-03-17 13:57:26,ea01a465-d72f-4a0c-ab8c-2f994a09ab42,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,14d69516-b5d0-4a14-bc6b-355661dea334,,no DMEM used / medium not clearly reported,f0062da1-9aed-4409-aa5b-4fff3a2c4df4,HAM F10/DMEM
Root,2022-03-24 18:23:59,ea01a465-d72f-4a0c-ab8c-2f994a09ab42,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,c6b033f0-6ecf-431d-90ca-769a66a16831,,no DMEM used / medium not clearly reported,326858f5-314c-482e-8500-244d1b12170c,
Root,2022-03-24 15:52:49,eaa56090-25f2-41ab-b55a-af561ee05275,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,60542e7a-3d15-407f-a223-32c6a563189a,,no DMEM used / medium not clearly reported,a489c743-d494-49ef-8e08-76b811c01468,
Root,2022-03-26 18:40:12,eaa56090-25f2-41ab-b55a-af561ee05275,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,2e7a84f0-31f7-41a3-8dfd-b51c71af9e09,,no DMEM used / medium not clearly reported,8f3d946d-746d-40a2-8abb-81abbc6ad58c,Eagle’s minimal essential medium
Root,2022-03-21 16:20:22,eb84584e-d8b8-4680-8a6c-d2428b2377a7,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,f1001369-8e5d-4895-8a11-0036330f9a79,,,,
Root,2022-03-25 13:20:58,eb84584e-d8b8-4680-8a6c-d2428b2377a7,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,172ed09a-f6b2-4a82-bd0a-e6ad2b441c12,,,,
Root,2022-03-22 10:55:18,ed55683d-39f4-4d95-a0ee-d8bca01c8d96,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,7e5b774c-adcd-4d92-a268-ccf215a22412,,no in vitro experiment with single Temozolomide (TMZ) treatment on U-87 MG cells,49be219a-e26a-46e1-a983-217c7a980ddf,
Root,2022-03-24 12:44:53,ed55683d-39f4-4d95-a0ee-d8bca01c8d96,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,0a79323a-d9ec-4092-860e-5c0778a26261,,no DMEM used / medium not clearly reported,621d50ba-92f7-40a9-96fa-62749cbad952,
Root,2022-03-24 18:11:59,f3052da8-0d73-4368-a275-bdeb53adb956,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,2e11fcb0-fb65-4d71-9f2e-0cd961c3a5ed,,,,
Root,2022-03-27 12:02:02,f3052da8-0d73-4368-a275-bdeb53adb956,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,acdf83fd-39dd-4ef4-8b81-17d6d407f4d8,,,,
Root,2022-03-18 16:53:53,f70a412a-f5c2-4b0f-93c1-355530a1d447,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,9df0a1dd-b937-43b8-9c3a-7c926368075b,,,,
Root,2022-03-25 09:23:33,f70a412a-f5c2-4b0f-93c1-355530a1d447,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,89b6c245-ee09-4b94-a6f7-16c1841d525a,,,,
Root,2022-03-22 10:59:04,fa06b822-e67b-44ae-bb30-8b773cea3743,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,ec2a68e3-dedc-468f-be02-66544a5eac93,,no U87 cells,47f07fe4-2db1-4d16-ae24-573f8d62a693,transfected U87 cells
Root,2022-03-24 15:28:28,fa06b822-e67b-44ae-bb30-8b773cea3743,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,ef6c83b5-e4a0-4f8e-a76f-85e79daf6db0,,,,
Root,2022-03-24 13:27:52,fa4b6854-fa9f-4164-baca-3311fd4a21e4,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,4f61925a-e8a5-4ade-9b84-baaae613a6ac,,,,
Root,2022-03-25 19:10:39,fa4b6854-fa9f-4164-baca-3311fd4a21e4,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,a3440e7f-0f1c-41ac-aeab-ae9613e0e0ab,,,,
Root,2022-03-18 16:45:36,fbf9871d-416b-4e1e-b7e8-1d28bb2798e8,a92f6308-5fb6-4754-a80f-5fcead380da6,FALSE,2a42c665-60f9-4d3a-9f47-07280ef2fbe9,,no DMEM used / medium not clearly reported,cb4601c9-7e8f-426f-91df-ce9cb53b21c8,U87 cells were routinely cultured in MEM (Minimum Essential Medium) or DMEM (Dulbecco’s Modified Eagle Medium)
Root,2022-03-24 08:39:00,fbf9871d-416b-4e1e-b7e8-1d28bb2798e8,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,TRUE,99f73320-eef2-4894-b1df-59766398740d,,,,
Root,2022-03-17 13:03:49,fc6c899d-5702-48d4-908c-0eb27ba33f88,a92f6308-5fb6-4754-a80f-5fcead380da6,TRUE,c8f6f740-9ea8-44f3-a5ba-f58eeb7bfa87,,,,
Root,2022-03-24 18:48:21,fc6c899d-5702-48d4-908c-0eb27ba33f88,e368d6d0-eeb5-42aa-8aee-4de0c8530da3,FALSE,a934c9f8-8eed-4909-b08b-bd859f6d56c2,,no DMEM used / medium not clearly reported,a6bd8a4a-e715-4cce-afd7-354b38d1c1e0,
